Actavis Totowa Recalls All Digitek Tablets Sold Under the Labels "Bertek" and "UDL" Because of Possible Double Dose

WASHINGTON, April 28 (UPI) -- The U.S. Food and Drug Administration announced the recall of Digitek-brand digoxin heart tablets because of a potential safety risk. The FDA said Actavis Totowa LLC, formerly known as Amide Pharmaceutical Inc. of Totowa, N.J., reported some tablets may be double the appropriate thickness and contain twice the approved level of active ingredient.

Back to news